Drug Type Unknown |
Synonyms- |
Target |
Action inhibitors |
Mechanism USP1 inhibitors(ubiquitin specific peptidase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | United States | 29 Apr 2025 | |
| Breast Cancer | Preclinical | United States | 29 Apr 2025 | |
| Breast Cancer | Preclinical | India | 29 Apr 2025 | |
| Ovarian Cancer | Preclinical | United States | 29 Apr 2025 | |
| Ovarian Cancer | Preclinical | United States | 29 Apr 2025 | |
| Ovarian Cancer | Preclinical | India | 29 Apr 2025 | |
| Prostatic Cancer | Preclinical | United States | 29 Apr 2025 | |
| Prostatic Cancer | Preclinical | United States | 29 Apr 2025 | |
| Prostatic Cancer | Preclinical | India | 29 Apr 2025 |





